Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (71-80 of 573) with videos related to

Pageof 58
Sort By:
Cancer|June 1, 1984
Chemotherapy in hairy cell leukemia. Preliminary results of a nonaggressive regimenL Annino, L Tentori, G Cameli, et al.
Chronobiologia|September 1, 1974
Clinical evaluation of corticoid therapy in haematologyF Mandelli, P Anselmo, R Cesaria, et al.
Blood|June 15, 1990
BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remissionG Meloni, P De Fabritiis, M C Petti, et al.
Blood|June 15, 1997
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantationG Meloni, S Capria, M Vignetti, et al.
Haematologica|March 1, 1975
Factor VIII inhibitors: a new therapeutical approachF Mandelli, E Malizia, L Signore, et al.
Leukemia|January 1, 1991
The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institutionC Guglielmi, S Amadori, M Martelli, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1987
[Granulocytopenia in oncohematology]F Mandelli, G Avvisati, S Fenu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatmentM Breccia, M Muscaritoli, Z Aversa, et al.
Leukemia|January 1, 1991
Clinical and pathological restaging in aggressive non-Hodgkin's lymphomasF Mandelli, S Amadori, C Guglielmi, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1980
The expanding spectrum of clinical and laboratory features of IgE myeloma. (Report of a case and review of the literature)F Dammacco, A Miglietta, M Tribalto, et al.
Pageof 58

Showing results (71-80 of 573) with videos related to

Sort By:
Pageof 58
Cancer|June 1, 1984
Chemotherapy in hairy cell leukemia. Preliminary results of a nonaggressive regimenL Annino, L Tentori, G Cameli, et al.
Chronobiologia|September 1, 1974
Clinical evaluation of corticoid therapy in haematologyF Mandelli, P Anselmo, R Cesaria, et al.
Blood|June 15, 1990
BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remissionG Meloni, P De Fabritiis, M C Petti, et al.
Blood|June 15, 1997
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantationG Meloni, S Capria, M Vignetti, et al.
Haematologica|March 1, 1975
Factor VIII inhibitors: a new therapeutical approachF Mandelli, E Malizia, L Signore, et al.
Leukemia|January 1, 1991
The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institutionC Guglielmi, S Amadori, M Martelli, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1987
[Granulocytopenia in oncohematology]F Mandelli, G Avvisati, S Fenu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatmentM Breccia, M Muscaritoli, Z Aversa, et al.
Leukemia|January 1, 1991
Clinical and pathological restaging in aggressive non-Hodgkin's lymphomasF Mandelli, S Amadori, C Guglielmi, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1980
The expanding spectrum of clinical and laboratory features of IgE myeloma. (Report of a case and review of the literature)F Dammacco, A Miglietta, M Tribalto, et al.
Pageof 58